Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 26:13:868942.
doi: 10.3389/fgene.2022.868942. eCollection 2022.

Description of the Molecular and Phenotypic Spectrum of Lesch-Nyhan Disease in Eight Chinese Patients

Affiliations

Description of the Molecular and Phenotypic Spectrum of Lesch-Nyhan Disease in Eight Chinese Patients

Lu Li et al. Front Genet. .

Abstract

Background: Lesch-Nyhan disease (LND) is a rare disorder involving pathogenic variants in the HPRT1 gene encoding the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGPRT) that result in hyperuricemia, intellectual disability, dystonic movement disorder, and compulsive self-mutilation. The purpose of the present study was to characterize the genetic basis of LND and describe its phenotypic heterogeneity by identifying the variation in the HPRT1 gene in a cohort of Chinese LND patients. Results: The median age at diagnosis was 31 mo (interquartile range (IQR): 7-76 mo), and the initial manifestations were mainly head control weakness and motor development delay. The median age of self-mutilation behavior onset was 19 mo (IQR: 17-24 mo), and all patients were required to travel in a wheelchair and fall into the predicament of compulsive self-harm behavior. There were two patients whose blood uric acid levels were normal for their high urinary acid excretion fraction without taking uric acid-lowering drugs. Seven different pathogenic variants of the HPRT1 gene were identified among eight independent pedigrees, including four novel mutations [c.299 (exon 3) T > A; loss (exon: 6) 84 bp; c.277_281delATTGC; c.468_470delGAT]. The pathogenic variant sites were mainly concentrated in exon 3, and truncating mutations (including frameshift mutations and nonsense mutations) were the most common genetic variant types (5/7, 71.4%). Conclusion: The present study described the phenotypic and molecular spectrum of LND in eight Chinese families, including four novel mutations, which expands our understanding of LND.

Keywords: HPRT1 gene; Lesch-Nyhan disease; dystonia; hyperuricemia; self-mutilation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Self-mutilation symptoms in LND. (A): Patient 2’s right lower lip became thinner (red arrow) due to his bite, and the lower central and lateral incisors were also worn away by himself (green arrow). (B): Patient 1’s lower lip became thinner (red arrow), and the tongue became shorter due to long-term self-injurious behaviour (SIB). (C): Patient 6’s lip became mutilated due to SIB (red arrow), and the tip of his tongue was often battered by his bite (black arrow). (D): Bitting of the mucosa in patient 8 (blue arrow).
FIGURE 2
FIGURE 2
Crystalline urine in patient 8 of LND. (A): Small white crystals deposited in urine (B): small crystals after centrifugal precipitation, (C): microscope (×200): square columnar magnesium ammonium phosphate crystal with strong refraction (black arrow).
FIGURE 3
FIGURE 3
Pathogenic variants of the HPRT1 gene (bold, novel mutation) in eight unrelated Chinese families with Lesch-Nyhan disease. Most are private genetic variants, p. R51X,168, which were confirmed in two families.

Similar articles

Cited by

References

    1. Allen S. M., Rice S. N. (1996). Risperidone Antagonism of Self-Mutilation in a Lesch-Nyhan Patient. Prog. Neuro-Psychopharmacology Biol. Psychiatry 20 (5), 793–800. 10.1016/0278-5846(96)00059-0 - DOI - PubMed
    1. Ambarsari C. G., Cahyadi D., Sari L., Satria O., Sahli F., Darmadi T. L., et al. (2020). Late Diagnosis of Lesch-Nyhan Disease Complicated with End-Stage Renal Disease and Tophi Burst: a Case Report. Ren. Fail. 42 (1), 113–121. 10.1080/0886022X.2020.1713805 - DOI - PMC - PubMed
    1. Bertelli M., Randi D., Micheli V., Gallo S., Andrighetto G., Parmigiani P., et al. (2004). Molecular Basis of Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency in Italian Lesch-Nyhan Patients: Identification of Nine Novel Mutations. J. Inherit. Metab. Dis. 27 (6), 767–773. 10.1023/B:BOLI.0000045799.78633.23 - DOI - PubMed
    1. Cho J. H., Choi J.-H., Heo S. H., Kim G.-H., Yum M.-S., Lee B. H., et al. (2019). Phenotypic and Molecular Spectrum of Korean Patients with Lesch-Nyhan Syndrome and Attenuated Clinical Variants. Metab. Brain Dis. 34 (5), 1335–1340. 10.1007/s11011-019-00441-0 - DOI - PubMed
    1. Cotton A. C., Bell R. B., Jinnah H. A. (2018). Expert Opinion vs Patient Perspective in Treatment of Rare Disorders: Tooth Removal in Lesch-Nyhan Disease as an Example. JIMD Rep. 41, 25–27. 10.1007/8904_2017_80 - DOI - PMC - PubMed